Titan Biotech (BOM:524717) E10: ₹4.74 (As of Mar. 2026)


BOM:524717 Titan Biotech Ltd BOM:524717
58 GF Score
Price ₹408.55
GF Value ₹144.50
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Titan Biotech E10?

Titan Biotech BOM:524717 +5.00% 58 E10 is ₹4.74 as of Mar. 2026. GuruFocus rates BOM:524717 with a GF Score™ of 58/100 and a GF Value™ of ₹144.50 (Significantly Overvalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Titan Biotech's adjusted earnings per share data for the three months ended in Mar. 2026 was ₹1.630. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹4.74 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Titan Biotech's average E10 Growth Rate was 20.90% per year. During the past 3 years, the average E10 Growth Rate was 20.30% per year. During the past 5 years, the average E10 Growth Rate was 25.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Titan Biotech was 30.40% per year. The lowest was 20.30% per year. And the median was 24.10% per year.

As of today (2026-07-07), Titan Biotech's current stock price is ₹408.55. Titan Biotech's E10 for the quarter that ended in Mar. 2026 was ₹4.74. Titan Biotech's Shiller PE Ratio of today is 86.19.

During the past 13 years, the highest Shiller PE Ratio of Titan Biotech was 106.33. The lowest was 14.47. And the median was 27.14.


Titan Biotech  (BOM:524717) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Titan Biotech's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=408.55/4.74
=86.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Titan Biotech was 106.33. The lowest was 14.47. And the median was 27.14.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Titan Biotech E10 Related Terms


Titan Biotech E10 Historical Data

* Premium members only.

The historical data trend for Titan Biotech's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Titan Biotech E10 Chart

Titan Biotech Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.05 2.72 3.37 3.92 4.74

Titan Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.92 4.12 4.36 4.57 4.74

BOM:524717 vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, Titan Biotech's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Titan Biotech Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Titan Biotech's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Titan Biotech's Shiller PE Ratio falls into.


BOM:524717
58GF Score
Titan Biotech Ltd BOM:524717
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Titan Biotech E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Titan Biotech's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.63/164.2724*164.2724
=1.630

Current CPI (Mar. 2026) = 164.2724.

Titan Biotech Quarterly Data

per share eps CPI Adj_EPS
201606 0.116 105.961 0.180
201609 0.144 105.961 0.223
201612 0.074 105.196 0.116
201703 0.228 105.196 0.356
201706 0.157 107.109 0.241
201709 0.103 109.021 0.155
201712 0.201 109.404 0.302
201803 0.342 109.786 0.512
201806 0.224 111.317 0.331
201809 0.282 115.142 0.402
201812 0.220 115.142 0.314
201903 0.160 118.202 0.222
201906 0.474 120.880 0.644
201909 0.344 123.175 0.459
201912 0.426 126.235 0.554
202003 0.466 124.705 0.614
202006 3.084 127.000 3.989
202009 1.744 130.118 2.202
202012 1.604 130.889 2.013
202103 0.910 131.771 1.134
202106 2.112 134.084 2.588
202109 1.548 135.847 1.872
202112 1.266 138.161 1.505
202203 0.324 138.822 0.383
202206 1.816 142.347 2.096
202209 2.208 144.661 2.507
202212 0.790 145.763 0.890
202303 1.198 146.865 1.340
202306 1.491 150.280 1.630
202309 1.578 151.492 1.711
202312 1.736 152.924 1.865
202403 1.208 153.035 1.297
202406 1.548 155.789 1.632
202409 1.620 157.882 1.686
202412 1.062 158.323 1.102
202503 0.980 157.552 1.022
202506 1.660 159.755 1.707
202509 1.880 162.289 1.903
202512 2.064 163.281 2.077
202603 1.630 164.272 1.630

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹4.74 mean?
Titan Biotech (BOM:524717) has a E10 of ₹4.74 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Titan Biotech and its competitors.
Is Titan Biotech's E10 too high?
Titan Biotech's current E10 is ₹4.74. Overall, Titan Biotech has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Titan Biotech's E10 compare to VRTX and REGN?
Titan Biotech's E10 of ₹4.74 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Titan Biotech and its competitors. Titan Biotech's current E10 is ₹4.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Titan Biotech stock overvalued right now?
Based on GuruFocus' analysis, Titan Biotech (BOM:524717) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹144.50, compared to a current price of ₹408.55 — trading 182.7% above its estimated fair value. The current E10 is ₹4.74. Titan Biotech's overall GF Score™ is 58/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Titan Biotech (BOM:524717), the current E10 is ₹4.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Titan Biotech (BOM:524717) Overvalued in 2026?

Based on GuruFocus' analysis, Titan Biotech stock appears to be overvalued. The current stock price of ₹408.55 is trading 182.7% above its estimated GF Value™ of ₹144.50. GuruFocus considers Titan Biotech to be Significantly Overvalued.

Key valuation signals for BOM:524717:

  • E10: ₹4.74
  • GF Value™: ₹144.50 vs. price of ₹408.55 (182.7% above fair value)
  • GF Score™: 58/100 with 2 warning signs

No single metric tells the full story. See the BOM:524717 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Titan Biotech Business Description

Address Netaji Subhash Place, 903-909, 9th Floor, Bigjos Tower, New Delhi, IND, 110034
Titan Biotech Ltd is a manufacturer and exporter of biological products. It manufactures biological products such as peptone, malt extract, yeast extract, liver extract, bile extract, culture media, laboratory chemicals, plant growth promoters, and others. The biological products have applications in the field of pharmaceutical, nutraceutical, food and beverages, biotechnology and fermentation, cosmetic, veterinary and animal feed, agriculture industries, and others. The company's business activity falls within a single primary business segment, which is the business of Biological Products. The firm sells its products in India and also exports internationally, of which the majority of the revenue is derived from the sales made in India.
58GF Score

Get the complete analysis for BOM:524717

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹408.55
Price
₹144.50
GF Value